Activiomics Inks $805,000

Activiomics Ltd. - a developer of technologies focused on the ways drug bio-markers are identified, and diagnostics are developed - has inked 500,000 pounds ($805,000) in financing. IP Group plc led the round, which included participation from IP Venture Fund and members of the company’s management.

14 March 2011•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail